Trial Profile

A proof of concept trial assessing VIS513 for the treatment of dengue fever

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 22 Nov 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs VIS 513 (Primary)
Indications Dengue
Focus Proof of concept; Therapeutic Use

Most Recent Events

22 Nov 2019 New trial record
21 May 2015 According to a Visterra Inc. media release, this study will be conducted under the collaboration of Drug Discovery & Development (D3) unit under the Agency for Science, Technology and Research (A*STAR) and Visterra.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com